Antigen Scientific and Production Enterprise LLP

Antigen Scientific and Production Enterprise LLP (ТОО Научно-производственное предприятие «Антиген») is a Kazakhstani scientific and production company based in Almaty. It operates at the intersection of biotechnology, veterinary science and medicine, focusing on the development, manufacture and deployment of immunobiological preparations and diagnostic test systems. According to its official website, the company positions itself as a leader in the development, production and introduction of next-generation biotechnological products in Kazakhstan. The company's stated key directions include developing new biotechnological solutions against infectious diseases of viral, bacterial and parasitic etiology; producing immunobiological preparations and diagnostic test systems that ensure safety and efficacy at every stage; and introducing innovative products to raise the level of epidemiological safety in society and the agricultural sector. Its products are described as being developed with attention to the unique characteristics of the region's epidemiological situation and as being used both in Kazakhstan and beyond its borders. Antigen states that it works to the strict international standards GMP, GLP and GDP. Its official homepage reports 122 qualified employees, 34 active and completed scientific and technical projects and programs, 124 publications in rated journals and scientific conferences, and 7,000 m² of production premises and laboratories. The company presents its core values as effectiveness, reliability and safety. As a limited liability partnership (ТОО / LLP), Antigen is a privately held entity. It is headquartered in Almaty, Kazakhstan, and its official website is antigen.kz. The company serves both the public health and agricultural sectors, supplying immunobiological and diagnostic products intended to protect human and animal health.

Antigen Scientific and Production Enterprise LLP is a Kazakhstani scientific and production company headquartered in Almaty. It was established as a limited liability partnership (ТОО) and operates at the intersection of biotechnology, veterinary science and medicine. The company's official website describes it as a leader in the development, production and introduction of next-generation biotechnological products in Kazakhstan. From its founding, the enterprise has concentrated on immunobiological preparations and diagnostic test systems. Its stated mission is to combine science, technology and experience to create effective solutions aimed at protecting human and animal health. The company reports that it has carried out 34 active and completed scientific and technical projects and programs and has produced 124 publications in rated journals and scientific conferences, reflecting a research-driven orientation. Antigen states that it works to the strict international standards GMP, GLP and GDP, and that its products are developed with attention to the unique characteristics of the region's epidemiological situation. Its products are described as being used both within Kazakhstan and abroad. The company's key directions include developing new biotechnological solutions against infectious diseases of viral, bacterial and parasitic etiology; manufacturing immunobiological preparations and diagnostic test systems; and introducing innovative products to improve epidemiological safety in society and the agricultural sector. As of its official homepage, the enterprise reports 122 qualified employees and 7,000 m² of production premises and laboratories. It is a privately held limited liability partnership based in Almaty, Kazakhstan, and maintains an official website at antigen.kz.

Leader in the development, production and introduction of next-generation biotechnological products in Kazakhstan, operating to GMP, GLP and GDP standards.

• Immunobiological preparations

  Preparations developed and manufactured for the prevention and control of infectious diseases.

• Diagnostic test systems

  Diagnostic test systems designed to ensure safety and efficacy at every stage.

1. 1Производство иммунобиологических препаратов в Казахстане | НПП Антигенantigen.kz
2. 2Antigen Scientific and Production Enterprise LLP (Kazakhstan) - Wikidatawikidata.org